Open Accessibility Menu

Coronavirus (COVID-19) Vaccine Update Click here to learn more.

For information about COVID-19 or to view additional resources, please click here.

Clinical Trial Information

A Multicenter, Randomized, Double-Blinded, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Topically Applied Sofpironium Bromide Gel, 15% in Subjects with Axillary Hyperhidrosis

Study Details

Main inclusion criteria:

  1. Male or female subject ≥9 years of age in good general health.
  2. Diagnosis of primary axillary hyperhidrosis in the opinion of the Investigator that meets all the following criteria:
    • a. HDSM-Ax-72 of 3-4 inclusive at both of the Screening visits (Visits 1 and 4)
    • c. Symptoms of axillary hyperhidrosis for >6 months’ duration

Primary Sponsor:

Brickell Biotech

Prinicipal Investigator:

Dr. Jonathan Silverberg

Contact Phone:

(202) 667-6160
A Multicenter, Randomized, Double-Blinded, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Topically Applied Sofpironium Bromide Gel, 15% in Subjects with Axillary Hyperhidrosis ntolstoy@mfa.gwu.edu

Interested in More Information

  • Please enter your first name.
  • Please enter your last name.
  • This isn't a valid email address.
    Please enter your email address.
  • This isn't a valid phone number.
    Please enter your phone number.
    You entered an invalid number.
  • Please enter your address.
  • Please enter your city.
  • Please enter your state.
  • Please enter your zip code.
  • (All Uppercase. No Spaces)